Published in Mol Biol Cell on May 01, 1998
Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides. Nucleic Acids Res (2000) 1.25
Rapid, diffusional shuttling of poly(A) RNA between nuclear speckles and the nucleoplasm. Mol Biol Cell (2005) 1.21
Antisense oligonucleotides: treating neurodegeneration at the level of RNA. Neurotherapeutics (2013) 1.10
Minute virus of mice NS1 interacts with the SMN protein, and they colocalize in novel nuclear bodies induced by parvovirus infection. J Virol (2002) 1.08
Polymersome delivery of siRNA and antisense oligonucleotides. J Control Release (2008) 1.04
TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells. Nucleic Acids Res (2014) 1.02
Phosphorothioate oligonucleotides can displace NEAT1 RNA and form nuclear paraspeckle-like structures. Nucleic Acids Res (2014) 0.95
A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells. Nucleic Acids Res (2015) 0.85
Use of a novel 5'-regioselective phosphitylating reagent for one-pot synthesis of nucleoside 5'-triphosphates from unprotected nucleosides. Curr Protoc Nucleic Acid Chem (2013) 0.81
Nuclear domain 10-associated proteins recognize and segregate intranuclear DNA/protein complexes to negate gene expression. Virol J (2012) 0.78
Protein Kinase C-α is a Critical Protein for Antisense Oligonucleotide-mediated Silencing in Mammalian Cells. Mol Ther (2016) 0.76
Monitoring integrity and localization of modified single-stranded RNA oligonucleotides using ultrasensitive fluorescence methods. PLoS One (2017) 0.75
The B-subdomain of the Xenopus laevis XFIN KRAB-AB domain is responsible for its weaker transcriptional repressor activity compared to human ZNF10/Kox1. PLoS One (2014) 0.75
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16
Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. Nature (1990) 8.79
Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature (1992) 8.45
Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci U S A (1980) 7.33
RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J (1994) 6.17
Macromolecular domains within the cell nucleus. Annu Rev Cell Biol (1993) 5.90
Dynamic organization of DNA replication in mammalian cell nuclei: spatially and temporally defined replication of chromosome-specific alpha-satellite DNA sequences. J Cell Biol (1992) 4.39
Associations between distinct pre-mRNA splicing components and the cell nucleus. EMBO J (1991) 4.38
The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J (1994) 4.29
Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med (1996) 4.09
The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol (1996) 3.91
A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sci (1992) 3.91
The nonchromatin substructures of the nucleus: the ribonucleoprotein (RNP)-containing and RNP-depleted matrices analyzed by sequential fractionation and resinless section electron microscopy. J Cell Biol (1986) 3.90
Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science (1996) 3.74
Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol (1992) 3.42
Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies. J Immunol (1989) 3.13
Pre-mRNA splicing by complementation with purified human U1, U2, U4/U6 and U5 snRNPs. Nucleic Acids Res (1988) 2.86
The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J Virol (1997) 2.83
Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells. Nucleic Acids Res (1993) 2.72
Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem (1991) 2.65
Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science (1993) 2.56
In vivo analysis of the stability and transport of nuclear poly(A)+ RNA. J Cell Biol (1994) 2.52
Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat Med (1996) 2.39
Intron-dependent recruitment of pre-mRNA splicing factors to sites of transcription. J Cell Biol (1996) 2.23
Intracellular distribution of microinjected antisense oligonucleotides. Proc Natl Acad Sci U S A (1991) 2.22
Immunocytochemical analysis of the coiled body in the cell cycle and during cell proliferation. Proc Natl Acad Sci U S A (1993) 2.13
Nuclear bodies (NBs): a newly "rediscovered" organelle. Exp Cell Res (1992) 1.92
Differences in snRNP localization between transformed and nontransformed cells. Mol Biol Cell (1992) 1.79
Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J Biol Chem (1994) 1.76
Antisense oligonucleotide-directed cleavage of mRNA in Xenopus oocytes and eggs. EMBO J (1988) 1.75
Potent and selective inhibition of gene expression by an antisense heptanucleotide. Nat Biotechnol (1996) 1.74
Inhibition of RNA polymerase II transcription causes chromatin decondensation, loss of nucleolar structure, and dispersion of chromosomal domains. Exp Cell Res (1996) 1.65
Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes. J Invest Dermatol (1994) 1.63
Progress in antisense oligonucleotide therapeutics. Annu Rev Pharmacol Toxicol (1996) 1.60
Molecular analysis of the coiled body. J Cell Sci Suppl (1995) 1.59
Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J Immunol (1994) 1.59
PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res (1995) 1.54
Rapid nuclear accumulation of injected oligodeoxyribonucleotides. New Biol (1990) 1.45
Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest (1995) 1.44
The nuclear matrix: a heuristic model for investigating genomic organization and function in the cell nucleus. J Cell Biochem (1991) 1.41
hnRNP A1 binds promiscuously to oligoribonucleotides: utilization of random and homo-oligonucleotides to discriminate sequence from base-specific binding. Nucleic Acids Res (1996) 1.35
An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J Pharmacol Exp Ther (1997) 1.34
BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet (1997) 1.30
Antisense oligonucleotides: towards clinical trials. Trends Biotechnol (1996) 1.27
Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A (1994) 1.25
Modified oligonucleotides as therapeutic and diagnostic agents. Curr Opin Biotechnol (1995) 1.21
Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression. Cancer Res (1996) 1.12
Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity. Nucleic Acids Res (1992) 1.11
Phosphorothioate antisense oligodeoxynucleotides: questions of specificity. Trends Biotechnol (1996) 1.11
In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. EMBO J (1993) 1.07
Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J Immunol (1994) 1.05
Antisense technology and prospects for therapy of viral infections and cancer. Mol Med Today (1997) 0.98
Detection of ribonuclease H-generated mRNA fragments in human leukemia cells following reversible membrane permeabilization in the presence of antisense oligodeoxynucleotides. Antisense Res Dev (1995) 0.97
Characterization of the nuclear binding sites of oligodeoxyribonucleotides and their analogs. J Biol Chem (1993) 0.94
Advances in understanding the pharmacological properties of antisense oligonucleotides. Adv Pharmacol (1997) 0.94
Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells. J Biol Chem (1996) 0.93
Antisense oligonucleotides as inhibitors of signal transduction: development from research tools to therapeutic agents. Biochem Soc Trans (1996) 0.91
Phosphorothioate oligonucleotides bind in a non sequence-specific manner to the nucleolar protein C23/nucleolin. FEBS Lett (1995) 0.90
Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potency. Nucleic Acids Res (1996) 0.89
The therapeutic potential of antisense oligonucleotides. Bioessays (1995) 0.86
Major internal nuclear matrix proteins are common to different human cell types. J Cell Biochem (1997) 0.84
Fluorescence microscopic comparison of the binding of phosphodiester and phosphorothioate (antisense) oligodeoxyribonucleotides to subcellular structures, including intermediate filaments, the endoplasmic reticulum, and the nuclear interior. Antisense Nucleic Acid Drug Dev (1997) 0.83
Nuclear bodies in mouse splenic lymphocytes: II - Cytochemistry and autoradiography during stimulation by concanavalin A. Biol Cell (1983) 0.83
Progress in antisense therapeutics. Med Res Rev (1996) 0.82
Polyamine cytochemistry: localization and possible functions of polyamines. Int Rev Cytol (1992) 0.80
Formation of nuclear bodies in hepatocytes of estrogen-treated roosters. Mol Biol Cell (1995) 0.80
Ultrastructural immunolocalization of polyamines in HeLa cells subjected to fast-freezing fixation and freeze substitution. Histochem Cell Biol (1997) 0.78
A functional analysis of protooncogene Vav's role in adult human hematopoiesis. Blood (1996) 0.76
Digoxigenin-labeled phosphorothioate oligonucleotides: a new tool for the study of cellular uptake. Antisense Res Dev (1995) 0.76
The CATH database: an extended protein family resource for structural and functional genomics. Nucleic Acids Res (2003) 8.36
The dynamics of a pre-mRNA splicing factor in living cells. Nature (1997) 4.97
Dynamic organization of DNA replication in mammalian cell nuclei: spatially and temporally defined replication of chromosome-specific alpha-satellite DNA sequences. J Cell Biol (1992) 4.39
Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation. Cell (2001) 4.21
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol (1999) 4.11
Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J Cell Biol (1997) 3.95
In vivo evidence that transcription and splicing are coordinated by a recruiting mechanism. Cell (1993) 3.13
RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo. Mol Cell (1999) 3.10
Visualization of gene activity in living cells. Nat Cell Biol (2000) 2.88
Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J Biol Chem (1991) 2.65
Nascent pre-mRNA transcripts are associated with nuclear regions enriched in splicing factors. Genes Dev (1991) 2.62
Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo. J Cell Biol (1998) 2.60
Immunoelectron microscopic localization of snRNPs. Biol Cell (1983) 2.57
In vivo analysis of the stability and transport of nuclear poly(A)+ RNA. J Cell Biol (1994) 2.52
Fluorescence photooxidation with eosin: a method for high resolution immunolocalization and in situ hybridization detection for light and electron microscopy. J Cell Biol (1994) 2.48
The cellular organization of gene expression. Curr Opin Cell Biol (1998) 2.41
Applications of the green fluorescent protein in cell biology and biotechnology. Nat Biotechnol (1997) 2.33
U1 and U2 small nuclear RNAs are present in nuclear speckles. Proc Natl Acad Sci U S A (1992) 2.27
Intron-dependent recruitment of pre-mRNA splicing factors to sites of transcription. J Cell Biol (1996) 2.23
Disruption of pre-mRNA splicing in vivo results in reorganization of splicing factors. J Cell Biol (1994) 2.12
Nucleologenesis: U3 snRNA-containing prenucleolar bodies move to sites of active pre-rRNA transcription after mitosis. Mol Biol Cell (1994) 2.07
Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem (1994) 2.00
Purification and biochemical characterization of interchromatin granule clusters. EMBO J (1999) 1.99
Silver staining, immunofluorescence, and immunoelectron microscopic localization of nucleolar phosphoproteins B23 and C23. Chromosoma (1984) 1.88
Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J Clin Invest (1996) 1.76
Serine/threonine phosphatase 1 modulates the subnuclear distribution of pre-mRNA splicing factors. Mol Biol Cell (1996) 1.72
The dynamic organization of the perinucleolar compartment in the cell nucleus. J Cell Biol (1997) 1.64
Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes. J Invest Dermatol (1994) 1.63
Progress in antisense oligonucleotide therapeutics. Annu Rev Pharmacol Toxicol (1996) 1.60
Time-resolved analysis and visualization of dynamic processes in living cells. Proc Natl Acad Sci U S A (1999) 1.55
ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia (2002) 1.54
Compartmentalization of RNA processing factors within nuclear speckles. J Struct Biol (2000) 1.51
Taxonomy and phylogeny of industrial solvent-producing clostridia. Int J Syst Bacteriol (1995) 1.48
Colocalization of U1 and U2 small nuclear RNPs by immunocytochemistry. Biol Cell (1984) 1.43
Observations on the effects of formaldehyde on cockroaches and their flora: I. Survival of vaccinia virus-infected cockroaches during fumigation with formaldehyde. J Hyg (Lond) (1978) 1.42
Role of the intercellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J Clin Invest (1996) 1.38
Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element. Nucleic Acids Res (1991) 1.37
The perinucleolar compartment and transcription. J Cell Biol (1998) 1.37
Alterations in chromatin conformation are accompanied by reorganization of nonchromatin domains that contain U-snRNP protein p28 and nuclear protein p107. J Cell Biol (1985) 1.37
Redistribution of U-snRNPs during mitosis. Exp Cell Res (1986) 1.36
Differential distribution of factors involved in pre-mRNA processing in the yeast cell nucleus. Mol Cell Biol (1990) 1.33
Protein phosphorylation and the nuclear organization of pre-mRNA splicing. Trends Cell Biol (1997) 1.30
A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease. Gastroenterology (1998) 1.28
In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells. Nucleic Acids Res (1997) 1.28
Chemically modified oligonucleotides exhibit decreased immune stimulation in mice. J Pharmacol Exp Ther (2000) 1.28
Organization of the double-stranded RNA-activated protein kinase DAI and virus-associated VA RNAI in adenovirus-2-infected HeLa cells. J Cell Sci (1993) 1.28
Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol (2001) 1.27
Nucleolar accumulation of poly (A)+ RNA in heat-shocked yeast cells: implication of nucleolar involvement in mRNA transport. Mol Biol Cell (1995) 1.26
Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides. Nucleic Acids Res (2000) 1.25
Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues. Lab Invest (1997) 1.25
Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus. Nucleic Acids Res (1998) 1.22
Macromolecular domains containing nuclear protein p107 and U-snRNP protein p28: further evidence for an in situ nuclear matrix. Mol Cell Biochem (1986) 1.18
Immunocytochemical localization of casein kinase II during interphase and mitosis. J Cell Biol (1991) 1.15
Nonhistone protein BA is a glutathione S-transferase localized to interchromatinic regions of the cell nucleus. J Cell Biol (1986) 1.12
ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranes. Antisense Nucleic Acid Drug Dev (2001) 1.11
Role of H3K27 demethylases Jmjd3 and UTX in transcriptional regulation. Cold Spring Harb Symp Quant Biol (2011) 1.09
Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides. Exp Cell Res (1994) 1.09
Dynamic organization of pre-mRNA splicing factors. J Cell Biochem (1996) 1.06
Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J Immunol (1994) 1.05
Quantitative imaging of pre-mRNA splicing factors in living cells. Mol Biol Cell (2000) 1.04
Phosphorothioate oligodeoxynucleotides distribute similarly in class A scavenger receptor knockout and wild-type mice. J Pharmacol Exp Ther (2000) 1.04
A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis. J Biol Chem (2001) 1.04
The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides. J Biol Chem (1999) 1.02
Will the real splicing sites please light up? Curr Biol (1992) 1.02
Nucleolar accumulation of poly (A)+ RNA in heat-shocked yeast cells: implication of nucleolar involvement in mRNA transport. Mol Biol Cell (1996) 1.01
Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents. Anticancer Drug Des (1997) 1.01
Mechanism of phorbol ester inhibition of histamine-induced IP3 formation in cultured airway smooth muscle. Am J Physiol (1989) 1.01
Islet-activating protein inhibits leukotriene D4- and leukotriene C4- but not bradykinin- or calcium ionophore-induced prostacyclin synthesis in bovine endothelial cells. Proc Natl Acad Sci U S A (1986) 1.00
Observations on the effects of formaldehyde on cockroaches and their flora: II. Prolonged survival of cockroaches drinking formaldehyde or glutaraldehyde solutions. J Hyg (Lond) (1978) 1.00
A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis. Aliment Pharmacol Ther (2006) 0.97
Fully modified 2' MOE oligonucleotides redirect polyadenylation. Nucleic Acids Res (2001) 0.96
Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. Leukemia (2004) 0.95
Multiple splicing factors are released from endogenous complexes during in vitro pre-mRNA splicing. Mol Cell Biol (1989) 0.94
Somatic instability of carotenoid biosynthesis in the tomato ghost mutant and its effect on plastid development. Planta (1987) 0.93
Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells. J Biol Chem (1996) 0.93
Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia. Leukemia (2000) 0.93
Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes. Gene Ther (2003) 0.92
Observations of the effects of formaldehyde on cockroaches and their flora: III. The effect of formaldehyde in eliminating the normal gut flora. J Hyg (Lond) (1978) 0.92
Antisense oligonucleotides as inhibitors of signal transduction: development from research tools to therapeutic agents. Biochem Soc Trans (1996) 0.91
Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial. Aliment Pharmacol Ther (2006) 0.91
In vitro and in vivo pharmacologic activities of antisense oligonucleotides. Anticancer Drug Des (1991) 0.90
Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-alpha. Cancer Lett (1998) 0.89
Regulation of ICAM-1-mediated fibroblast-T cell reciprocal interaction: implications for modulation of gut inflammation. Gastroenterology (1999) 0.89
Inhibition of interleukin-1 type I receptor expression in human cell-lines by an antisense phosphorothioate oligodeoxynucleotide. Int J Immunopharmacol (1996) 0.89
Mammalian phosphoinositide-specific phospholipase C isoenzymes. Cell Calcium (1989) 0.87
A GH receptor antisense oligonucleotide inhibits hepatic GH receptor expression, IGF-I production and body weight gain in normal mice. J Endocrinol (2006) 0.86
Antisense oligonucleotides to the epidermal growth factor receptor. Breast Cancer Res Treat (1999) 0.86
Characterization of CoA-independent transacylase activity in U937 cells. Biochim Biophys Acta (1991) 0.85
Solubilization of rat liver vasopressin receptors as a complex with a guanine-nucleotide-binding protein and phosphoinositide-specific phospholipase C. Biochem J (1989) 0.85
The signal transduction system of the leukotriene D4 receptor. Trends Pharmacol Sci (1989) 0.84
Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis. Aliment Pharmacol Ther (2006) 0.84
ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leucocyte adherence and inflammation in rat inflammatory bowel disease. Gut (2002) 0.84
A role for c-Raf kinase and Ha-Ras in cytokine-mediated induction of cell adhesion molecules. J Biol Chem (1998) 0.83
Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity. J Pharmacol Exp Ther (2000) 0.83